Ewing's Sarcoma
This article was marked by its author as Under construction, but the last edit is older than 30 days. If you want to edit this page, please try to contact its author first (you fill find him in the history). Watch the discussion as well. If the author will not continue in work, remove the template Last update: Sunday, 19 Mar 2023 at 10.10 pm. |
Ewing's sarcoma (EWS) belongs to the sarcomas of the Ewing group: EWS, PNET (primitive neuroectodermal tumor), Askin's tumor (Ewing on the chest wall).
It is the 2nd most common malignant bone tumor in children and adolescents, the highest incidence between 5–30 years of age. Early metastasis to the lungs is typical.
It most often develops in the bone marrow of the diaphysis of long bones (mainly femur, tibia). It often mimics acute osteomyelitis: subfebrile, leukocytosis, increased sedimentation, pain, including positive scintigraphy.
Clinical picture: Pain, swelling, pathological fractures
RTG: osteolytic changes with permeative bone destruction + periosteal reaction.
Therapy: 1. neoadjuvant CHT , 2. radical surgical resection, 3. intraoperative / subsequent RT , 4. adjuvant CHT.
Prognosis: 5-year survival 60-76% (in case of no metastases).
References[edit | edit source]
Related Articles[edit | edit source]
Literature[edit | edit source]
- SOSNA, A., P. VAVŘÍK a M. KRBEC, et al. Základy ortopedie. 1st edition. Prague: Triton, 2001. ISBN 80-7254-202-8.
- DUNGL, P., et al. Orthopedics. 1st edition. Prague: Grada Publishing, 2005. ISBN 80-247-0550-8.
- GALLO, Jiří, et al. rthopedics for students of medical and health faculties 1st edition. Olomouc: Palacký University in Olomouc, 2011. ISBN 978-80-244-2486-6.